Comparative in vitro study of five mechanical embolectomy systems: effectiveness of clot removal and risk of distal embolization
- 236 Downloads
We report an in vitro study comparing the effectiveness of clot removal and clot fragmentation of five embolectomy systems.
A flow model was embolized with fresh and old thrombi, occluding an inner diameter of 2–5 mm simulating internal carotid artery (ICA), basilar artery (BA) and middle cerebral artery (MCA) branch occlusion. Embolectomy was performed using five retrieval systems: CATCH (Balt), Merci retriever (Concentric), InTime and Attracter (Boston Scientific), and the Phenox Clot Retriever (Phenox). Clot removal and evidence and type of thrombus fragmentation and distal embolization were recorded.
There were no observable differences attributable to thrombus age. The Merci, CATCH and Phenox Clot Retriever were equally able to mobilize and remove thrombi with the exception of one particularly firm clot. There were marked differences in terms of thrombus fragmentation and distal embolization. All devices produced micro- and macrofragments during penetration and retrieval. The Phenox Clot Retriever was able to filter fragments. The InTime and Attracter devices failed to retrieve thrombi in this model and achieved partial removal at best with a tendency towards thrombus displacement and fragmentation.
Within limits, the experimental setup was appropriate for generating occlusions of diameter 2–5 mm of various lengths, simulating ICA, BA and MCA thromboembolism. In this model, thrombus mobilization appeared to be less dependent upon the individual design of the retrieval system than on thrombus fragmentation. The ability to prevent distal embolization is, however, strongly dependent on the ability of a thrombectomy device to capture fragments that are generated during removal of the device.
KeywordsEndovascular Thrombectomy Stroke Ischemia Embolectomy
Conflict of interest statement
Ralf Hannes is an employee of Phenox GmbH. Elina Miloslavski is a consultant to Phenox GmbH. Hans Henkes is cofounder of Phenox GmbH and therefore has ownership interests.
- 2.Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH (1995) Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274(13):1017–1025PubMedCrossRefGoogle Scholar
- 3.Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F (1999) Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282(21):2003–2011PubMedCrossRefGoogle Scholar
- 5.Alexandrov AV, Demchuk AM, Felberg RA, Christou I, Barber PA, Burgin WS, Malkoff M, Wojner AW, Grotta JC (2000) High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial doppler monitoring. Stroke 31(3):610–614PubMedGoogle Scholar
- 6.Röther J, Schellinger PD, Gass A, Siebler M, Villringer A, Fiebach JB, Fiehler J, Jansen O, Kucinski T, Schoder V, Szabo K, Junge-Hulsing GJ, Hennerici M, Zeumer H, Sartor K, Weiller C, Hacke W, Kompetenznetzwerk Schlaganfall Study Group (2002) Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 hours. Stroke 33(10):2438–2445PubMedCrossRefGoogle Scholar
- 9.Chapot R (2005) First experience with the CATCH, a new device for cerebral thrombectomy. Interventional Neuroradiology 11 [Suppl 2]:56–58Google Scholar
- 14.Qureshi AI, Siddiqui AM, Suri MF, Kim SH, Ali Z, Yahia AM, Lopes DK, Boulos AS, Ringer AJ, Saad M, Guterman LR, Hopkins LN (2002) Aggressive mechanical clot disruption and low-dose intra-arterial third generation thrombolytic agent for ischemic stroke: a prospective study. Neurosurgery 51:1319–1329PubMedCrossRefGoogle Scholar